IP Library Patent Application 18150933
Patent Application
App. No. 18/150,933

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES AND METHODS OF USE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/150,933
Abstract

The present invention provides for a method of treating a disease such as cancer, comprising the step of administering to a patient a therapeutically effective amount of a perillyl alcohol derivative such as a perillyl alcohol ester, or an isoperillyl alcohol derivative such as an isoperillyl alcohol ester. The derivative may be a perillyl alcohol or an isoperillyl alcohol conjugated with a therapeutic agent such as valproic acid. The route of administration may vary, including inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.

Claims (9)

1 . A method for treating a disease in a mammal, the method comprising the step of administering to the mammal a therapeutically effective amount of a perillyl alcohol conjugated with valproic acid.

2 . The method of claim 1 , wherein the disease is cancer.

3 . The method of claim 2 , wherein the cancer is a tumor of the nervous system.

4 . The method of claim 3 , wherein the tumor is a glioblastoma.

5 . The method of claim 1 , further comprising the step of treating the mammal with radiation.

6 . The method of claim 1 , further comprising the step of administering to the mammal a chemotherapeutic agent.

7 . The method of claim 1 , wherein the perillyl alcohol conjugated with valproic acid is administered by inhalation, intranasally, orally, intravenously, subcutaneously or intramuscularly.

8 . A method for treating a disease in a mammal, comprising the step of administering to the mammal a therapeutically effective amount of a perillyl alcohol conjugated with valproic acid conjugated with valproic acid using a nasal delivery device.

9 . The method of claim 8 , wherein the nasal delivery device is selected from the group consisting of an intranasal inhaler, an intranasal spray device, an atomizer, a nebulizer, a metered dose inhaler (MDI), a pressurized dose inhaler, an insufflator, a unit dose container, a pump, a dropper, a squeeze bottle and a bi-directional device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2023
From: NEONC TECHNOLOGIES INC.
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 063726/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2023
From: CHEN, THOMAS; LEVIN, DANIEL; PUPPALI, SATISH
To: NEONC TECHNOLOGIES, INC.
Reel/Frame 062293/0990 →